|Bid||0.0820 x 14280600|
|Ask||0.0830 x 19968800|
|Day's Range||0.0800 - 0.0830|
|52 Week Range||0.0800 - 0.3600|
|Beta (5Y Monthly)||0.94|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 23, 2022 - Feb 28, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||0.22|
Subscribe to Yahoo Finance Plus to view Fair Value for EXL.AXLearn more
Elixinol Wellness Limited (Elixinol or the Company) (ASX:EXL; OTCQB:ELLXF) is pleased to communicate that Assembly Bill 45 (AB45) was signed into law by Californian Governor, Mr Gavin Newsom on 6 October 2021, establishing a comprehensive regulatory framework for the manufacture and retail sale of products in California containing hemp derived cannabidiol (CBD), including dietary supplements, topicals, over-the-counter, and pet products, among others.
Elixinol, a global hemp-derived CBD brand and industry veteran, introduced its first line of pet products. The new collection is specifically formulated for dogs and includes a bacon-flavored tincture and two functionally focused CBD dog chews targeting specific benefits. The collection is available now on Elixinol.com.
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...